|
PRIM2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.46749962076842E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.69035999999512E-05 |
| Normal-vs-Stage2 |
2.175100E-03 |
| Normal-vs-Stage3 |
1.97611999999125E-05 |
| Normal-vs-Stage4 |
6.399800E-02 |
| Stage1-vs-Stage2 |
1.732200E-01 |
| Stage1-vs-Stage3 |
5.459700E-03 |
| Stage1-vs-Stage4 |
7.116600E-01 |
| Stage2-vs-Stage3 |
4.140000E-01 |
| Stage2-vs-Stage4 |
6.047200E-01 |
| Stage3-vs-Stage4 |
2.401000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.41830003297372E-09 |
| Normal-vs-AfricanAmerican |
1.83093999999162E-05 |
| Normal-vs-Asian |
1.837380E-01 |
| Caucasian-vs-AfricanAmerican |
5.385800E-01 |
| Caucasian-vs-Asian |
8.382000E-01 |
| AfricanAmerican-vs-Asian |
9.761600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.97269999727234E-08 |
| Normal-vs-Female |
9.0522999984799E-08 |
| Male-vs-Female |
4.713900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.702900E-03 |
| Normal-vs-Extreme_Weight |
4.29699999999755E-05 |
| Normal-vs-Obese |
1.36339999956547E-07 |
| Normal-vs-Extreme_Obese |
6.028400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.362800E-01 |
| Normal_Weight-vs-Obese |
2.437600E-03 |
| Normal_Weight-vs-Extreme_Obese |
3.379400E-01 |
| Extreme_Weight-vs-Obese |
9.200600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
1.799770E-01 |
| Obese-vs-Extreme_Obese |
3.922300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.382200E-03 |
| Normal-vs-Age(41-60Yrs) |
3.08809977589419E-10 |
| Normal-vs-Age(61-80Yrs) |
1.50294999999856E-05 |
| Normal-vs-Age(81-100Yrs) |
2.117700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.780000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.069800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.240300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.476960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.123910E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.648170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.89150000901628E-09 |
| Normal-VS-Type2 PRCC |
5.56419999999669E-05 |
| Normal-VS-KIRP CIMP |
1.874280E-02 |
| Normal-VS-Unclassified PRCC |
3.176500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.154200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.010200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.277600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.688400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.942800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.078400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.543250E-03 |
| Normal-vs-N1 |
8.414900E-04 |
| Normal-vs-N2 |
5.510000E-01 |
| N0-vs-N1 |
1.092160E-02 |
| N0-vs-N2 |
9.253000E-01 |
| N1-vs-N2 |
2.950400E-01 |
|
|
